Evolent Health [EVH] vs Ge Healthcare [GEHC] Detailed Stock Comparison
Evolent Health
NYSE
Loading...
Ge Healthcare
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Evolent Health wins in 7 metrics, Ge Healthcare wins in 12 metrics, with 0 ties. Ge Healthcare appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Evolent Health | Ge Healthcare | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -11.11 | 15.03 | Evolent Health |
| Price-to-Book Ratio | 1.16 | 3.45 | Evolent Health |
| Debt-to-Equity Ratio | 75.85 | 107.67 | Evolent Health |
| PEG Ratio | -0.02 | 1.18 | Evolent Health |
| EV/EBITDA | 27.33 | 11.09 | Ge Healthcare |
| Profit Margin (TTM) | -5.94% | 11.22% | Ge Healthcare |
| Operating Margin (TTM) | 0.64% | 14.62% | Ge Healthcare |
| EBITDA Margin (TTM) | 0.64% | 14.62% | Ge Healthcare |
| Return on Equity | -11.04% | 25.80% | Ge Healthcare |
| Return on Assets (TTM) | -0.21% | 5.77% | Ge Healthcare |
| Free Cash Flow (TTM) | $-6.13M | $1.55B | Ge Healthcare |
| Dividend Yield | N/A | 0.24% | N/A |
| 1-Year Return | -73.40% | -13.72% | Ge Healthcare |
| Price-to-Sales Ratio (TTM) | 0.48 | 1.68 | Evolent Health |
| Enterprise Value | $1.97B | $40.73B | Ge Healthcare |
| EV/Revenue Ratio | 0.90 | 2.04 | Evolent Health |
| Gross Profit Margin (TTM) | 22.59% | 39.65% | Ge Healthcare |
| Revenue per Share (TTM) | $19 | $44 | Ge Healthcare |
| Earnings per Share (Diluted) | $-1.60 | $4.88 | Ge Healthcare |
| Beta (Stock Volatility) | 0.82 | 1.28 | Evolent Health |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Evolent Health vs Ge Healthcare Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Evolent Health | 9.35% | -0.57% | -10.14% | 9.63% | -15.92% | -23.67% |
| Ge Healthcare | 2.82% | -0.69% | -1.36% | 5.13% | -19.69% | -6.67% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Evolent Health | -73.40% | -76.04% | -35.75% | -48.92% | -53.50% | -53.50% |
| Ge Healthcare | -13.72% | 28.92% | 28.92% | 28.92% | 28.92% | 28.92% |
Performance & Financial Health Analysis: Evolent Health vs Ge Healthcare
| Metric | EVH | GEHC |
|---|---|---|
| Market Information | ||
| Market Cap | $1.04B | $33.48B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 4,274,290 | 3,179,722 |
| 90 Day Avg. Volume | 2,970,243 | 3,859,554 |
| Last Close | $9.59 | $75.21 |
| 52 Week Range | $7.06 - $33.63 | $57.65 - $94.80 |
| % from 52W High | -71.48% | -20.66% |
| All-Time High | $39.78 (Sep 12, 2022) | $94.80 (Feb 10, 2025) |
| % from All-Time High | -75.89% | -20.66% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.31% | 0.04% |
| Quarterly Earnings Growth | N/A | 0.14% |
| Financial Health | ||
| Profit Margin (TTM) | -0.06% | 0.11% |
| Operating Margin (TTM) | 0.01% | 0.15% |
| Return on Equity (TTM) | -0.11% | 0.26% |
| Debt to Equity (MRQ) | 75.85 | 107.67 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $7.73 | $21.27 |
| Cash per Share (MRQ) | $1.30 | $8.19 |
| Operating Cash Flow (TTM) | $-33,330,000 | $2.00B |
| Levered Free Cash Flow (TTM) | $-77,390,624 | $1.58B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.24% |
| Last 12-Month Dividend | N/A | $0.18 |
Valuation & Enterprise Metrics Analysis: Evolent Health vs Ge Healthcare
| Metric | EVH | GEHC |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -11.11 | 15.03 |
| Forward P/E | 6.29 | 15.70 |
| PEG Ratio | -0.02 | 1.18 |
| Price to Sales (TTM) | 0.48 | 1.68 |
| Price to Book (MRQ) | 1.16 | 3.45 |
| Market Capitalization | ||
| Market Capitalization | $1.04B | $33.48B |
| Enterprise Value | $1.97B | $40.73B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.90 | 2.04 |
| Enterprise to EBITDA | 27.33 | 11.09 |
| Risk & Other Metrics | ||
| Beta | 0.82 | 1.28 |
| Book Value per Share (MRQ) | $7.73 | $21.27 |
Financial Statements Comparison: Evolent Health vs Ge Healthcare
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | EVH | GEHC |
|---|---|---|
| Revenue/Sales | $483.65M | $4.78B |
| Cost of Goods Sold | $381.18M | $2.77B |
| Gross Profit | $102.47M | $2.01B |
| Research & Development | N/A | $344.00M |
| Operating Income (EBIT) | $4,000 | $628.00M |
| EBITDA | $25.27M | $842.00M |
| Pre-Tax Income | $-63.15M | $692.00M |
| Income Tax | $1.47M | $104.00M |
| Net Income (Profit) | $-64.62M | $588.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | EVH | GEHC |
|---|---|---|
| Cash & Equivalents | $246.55M | $2.45B |
| Total Current Assets | $727.93M | $9.74B |
| Total Current Liabilities | $739.10M | $9.97B |
| Long-Term Debt | $663.12M | $7.06B |
| Total Shareholders Equity | $935.52M | $9.42B |
| Retained Earnings | $-845.44M | $3.81B |
| Property, Plant & Equipment | $5.73M | $369.00M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | EVH | GEHC |
|---|---|---|
| Operating Cash Flow | $-23.39M | $509.00M |
| Capital Expenditures | N/A | $-152.00M |
| Free Cash Flow | $-4.03M | $98.00M |
| Debt Repayment | $-62.50M | $-257.00M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | EVH | GEHC |
|---|---|---|
| Shares Short | 18.83M | 9.02M |
| Short Ratio | 7.11 | 2.31 |
| Short % of Float | 0.16% | 0.03% |
| Average Daily Volume (10 Day) | 4,274,290 | 3,179,722 |
| Average Daily Volume (90 Day) | 2,970,243 | 3,859,554 |
| Shares Outstanding | 115.04M | 456.96M |
| Float Shares | 91.32M | 455.28M |
| % Held by Insiders | 0.02% | 0.00% |
| % Held by Institutions | 1.09% | 0.87% |
Dividend Analysis & Yield Comparison: Evolent Health vs Ge Healthcare
| Metric | EVH | GEHC |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.18 |
| Last 12-Month Dividend Yield | N/A | 0.24% |
| 3-Year Avg Annual Dividend | N/A | $0.11 |
| 3-Year Avg Dividend Yield | N/A | 0.04% |
| 3-Year Total Dividends | N/A | $0.33 |
| Ex-Dividend Date | N/A | Jul 25, 2025 |